State of the art for gastric signet ring cell carcinoma: from classification, prognosis, and genomic characteristics to specified treatments

References

• FerlayJSoerjomataramIDikshitRCancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012Int J Cancer20151365E359E38625220842
   PubMed Web of Science ®Google Scholar
• ZhangXYZhangPYGastric cancer: somatic Genetics as a guide to therapyJ Med Genet201754530531227609016
   PubMed Web of Science ®Google Scholar
• KimBSOhSTYookJHKimBSSignet ring cell type and other histologic types: differing clinical course and prognosis in T1 gastric cancerSurgery201415561030103524792508
   PubMed Web of Science ®Google Scholar
• GigekCOCalcagnoDQRasmussenLTGenetic variants in gastric cancer: risks and clinical implicationsExp Mol Pathol2017103110111128736214
   PubMed Web of Science ®Google Scholar
• TakatsuYHikiNNunobeSClinicopathological features of gastric cancer in young patientsGastric Cancer201619247247825752270
   PubMed Web of Science ®Google Scholar
• KunisakiCAkiyamaHNomuraMClinicopathological features of gastric carcinoma in younger and middle-aged patients: a comparative studyJ Gastrointest Surg20061071023103216843873
   PubMed Web of Science ®Google Scholar
• LlanosOButteJMCrovariFDuarteIGuzmanSSurvival of young patients after gastrectomy for gastric cancerWorld J Surg2006301172016369709
   PubMed Web of Science ®Google Scholar
• KongXWangJLChenHMFangJYComparison of the clinico-pathological characteristics of young and elderly patients with gastric carcinoma: a meta-analysisJ Surg Oncol2012106334635222331676
   PubMed Web of Science ®Google Scholar
• MilneANSitarzRCarvalhoRCarneiroFOfferhausGJEarly onset gastric cancer: on the road to unraveling gastric carcinogenesisCurr Mol Med200771152817311530
   PubMed Web of Science ®Google Scholar
• BamboatZMTangLHVinuelaEStage-stratified prognosis of signet ring cell histology in patients undergoing curative resection for gastric adenocarcinomaAnn Surg Oncol20142151678168524394986
   PubMed Web of Science ®Google Scholar
• TaghaviSJayarajanSNDaveyAWillisAIPrognostic significance of signet ring gastric cancerJ Clin Oncol201230283493349822927530
   PubMed Web of Science ®Google Scholar
• HensonDEDittusCYounesMNguyenHAlbores-SaavedraJDifferential trends in the intestinal and diffuse types of gastric carcinoma in the United States, 1973–2000: increase in the signet ring cell typeArch Pathol Lab Med2004128776577015214826
   PubMed Web of Science ®Google Scholar
• PengJXiaoPLiaoBYeJHeYAnalysis of clinicopathological features of 1879 cases of gastric cancer in Southern China: a single center experienceZhonghua Wai Ke Za Zhi2014523168170 Chinese24785452
   PubMedGoogle Scholar
• PernotSVoronTPerkinsGLagorce-PagesCBergerATaiebJSignet-ring cell carcinoma of the stomach: impact on prognosis and specific therapeutic challengeWorld J Gastroenterol20152140114281143826523107
   PubMed Web of Science ®Google Scholar
• MachlowskaJMaciejewskiRSitarzRThe pattern of signatures in gastric cancer prognosisInt J Mol Sci2018196E165829867026
   PubMed Web of Science ®Google Scholar
• SkieruchaMMilneANOfferhausGJAPolkowskiWPMaciejewskiRSitarzRMolecular alterations in gastric cancer with special reference to the early-onset subtypeWorld J Gastroenterol20162282460247426937134
   PubMed Web of Science ®Google Scholar
• SitarzRSkieruchaMMielkoJOfferhausGJAMaciejewskiRPolkowskiWPGastric cancer: epidemiology, prevention, classification, and treatmentCanc Manag Res201810239248
   Web of Science ®Google Scholar
• BerlthFBollschweilerEDrebberUHoelscherAHMoenigSPathohistological classification systems in gastric cancer: diagnostic relevance and prognostic valueWorld J Gastroenterol201420195679568424914328
   PubMed Web of Science ®Google Scholar
• LaurenPThe two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classificationActa Pathol Microbiol Scand196564314914320675
   PubMedGoogle Scholar
• VogelaarIPvan der PostRSvan KriekenJHJUnraveling genetic predisposition to familial or early onset gastric cancer using germline whole-exome sequencingEur J Hum Genet201725111246125228875981
   PubMed Web of Science ®Google Scholar
• BosmanFTCarneiroFHrubanRHTheise Nd: WHO Classification of Tumours of the Digestive System4th edLyon, FranceIARC2010
   Google Scholar
• LeocataPVenturaLGiuntaMGastric carcinoma: a histopatho-logical study of 705 casesAnn Ital Chir19986933313379835105
   PubMedGoogle Scholar
• LauwersGCarneiroFGrahamDCuradoMFranceschiSClassification of tumours of the digestive system4th edLyonIARC Press20104858
   Google Scholar
• Fenoglio-PreserCMunozNCarneiorFGastric carcinomaHamiltonSRAaltonenLAWorld Health Organization Classification of Tumours: Pathology and Genetics of Tumours of the Digestive SystemLyonIARC Press20003839
   Google Scholar
• FléjouJ-FClassification OMS 2010 des tumeurs digestives: la quatrième edition [WHO Classification of digestive tumors: the fourth edition]Ann Pathol2011315 SupplS27S31 French22054452
   PubMedGoogle Scholar
• HuBEl HajjNSittlerSLammertNBarnesRMeloni-EhrigAGastric cancer: classification, histology and application of molecular pathologyJ Gastrointest Oncol20123325126122943016
   PubMedGoogle Scholar
• SarbiaMBeckerKFHöflerHPathology of upper gastrointestinal malignanciesSemin Oncol200431446547515297939
   PubMed Web of Science ®Google Scholar
• WernerMBeckerKFKellerGHöflerHGastric adenocarcinoma: pathomorphology and molecular pathologyJ Cancer Res Clin Oncol2001127420721611315254
   PubMed Web of Science ®Google Scholar
• FukuiYMechanisms behind signet ring cell carcinoma formationBiochem Biophys Res Commun201445041231123325019985
   PubMed Web of Science ®Google Scholar
• VleminckxKVakaetLMareelMFiersWvan RoyFGenetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor roleCell19916611071192070412
   PubMed Web of Science ®Google Scholar
• CavallaroUChristoforiGCell adhesion and signalling by cadherins and Ig-CAMs in cancerNat Rev Cancer20044211813214964308
   PubMed Web of Science ®Google Scholar
• HumarBBlairVCharltonAMoreHMartinIGuilfordPE-cadherin deficiency initiates gastric signet-ring cell carcinoma in mice and manCanc Res200969520502056
   PubMed Web of Science ®Google Scholar
• ChiurilloMARole of the Wnt/β-catenin pathway in gastric cancer: an in-depth literature reviewWorld J Exp Med2015528410225992323
   PubMedGoogle Scholar
• KwonKJShimKNSongEMClinicopathological characteristics and prognosis of signet ring cell carcinoma of the stomachGastric Canc20141714353
   PubMed Web of Science ®Google Scholar
• HonoréCGoéréDMessagerMRisk factors of peritoneal recurrence in esogastric signet ring cell adenocarcinoma: results of a multicentre retrospective studyEur J Surg Oncol201339323524123313257
   PubMed Web of Science ®Google Scholar
• ZhangMZhuGZhangHGaoHXueYClinicopathologic features of gastric carcinoma with signet ring cell histologyJ Gastrointest Surg201014460160620033340
   PubMed Web of Science ®Google Scholar
• PiessenGMessagerMLeteurtreEJean-PierreTMarietteCSignet ring cell histology is an independent predictor of poor prognosis in gastric adenocarcinoma regardless of tumoral clinical presentationAnn Surg2009250687888719855261
   PubMed Web of Science ®Google Scholar
• LiCKimSLaiJFAdvanced gastric carcinoma with signet ring cell histologyOncology2007721–2646818004078
   PubMed Web of Science ®Google Scholar
• KimJPKimSCYangHKPrognostic significance of signet ring cell carcinoma of the stomachSurg Oncol1994342212277834113
   PubMed Web of Science ®Google Scholar
• RibeiroMMSarmentoJASobrinho SimõesMABastosJPrognostic significance of Lauren and Ming classifications and other pathologic parameters in gastric carcinomaCancer19814747807847226025
   PubMed Web of Science ®Google Scholar
• HassHGSmithUJägerCSignet ring cell carcinoma of the stomach is significantly associated with poor prognosis and diffuse gastric cancer (Lauren’s): single-center experience of 160 casesOnkologie2011341268268622156447
   PubMedGoogle Scholar
• JiangCGWangZNSunZLiuFNYuMXuHMClinicopathologic characteristics and prognosis of signet ring cell carcinoma of the stomach: results from a Chinese mono-institutional studyJ Surg Oncol2011103770070321308685
   PubMed Web of Science ®Google Scholar
• KunisakiCShimadaHNomuraMMatsudaGOtsukaYAkiyamaHTherapeutic strategy for signet ring cell carcinoma of the stomachBr J Surg200491101319132415376179
   PubMed Web of Science ®Google Scholar
• HaTKAnJYYounHKNohJHSohnTSKimSIndication for endoscopic mucosal resection in early signet ring cell gastric cancerAnn Surg Oncol200815250851318071825
   PubMed Web of Science ®Google Scholar
• KimDYParkYKJooJKClinicopathological characteristics of signet ring cell carcinoma of the stomachANZ J Surg200474121060106415574148
   PubMed Web of Science ®Google Scholar
• LeeJHChoiIJKookMCNamBHKimYWRyuKWRisk factors for lymph node metastasis in patients with early gastric cancer and signet ring cell histologyBr J Surg201097573273620235088
   PubMed Web of Science ®Google Scholar
• HyungWJNohSHLeeJHEarly gastric carcinoma with signet ring cell histologyCancer2002941788311815962
   PubMed Web of Science ®Google Scholar
• OtsujiEYamaguchiTSawaiKTakahashiTCharacterization of signet ring cell carcinoma of the stomachJ Surg Oncol19986742162209579367
   PubMed Web of Science ®Google Scholar
• GronnierCMessagerMRobbWBIs the negative prognostic impact of signet ring cell histology maintained in early gastric adeno-carcinoma?Surgery201315451093109924075273
   PubMed Web of Science ®Google Scholar
• KangSHKimJSMoonHSSignet ring cell carcinoma of early gastric cancer, is endoscopic treatment really risky?Medicine20179633e753228816940
   PubMed Web of Science ®Google Scholar
• GotodaTYanagisawaASasakoMIncidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centersGastric Canc200034219225
   PubMedGoogle Scholar
• YokotaTKuniiYTeshimaSSignet ring cell carcinoma of the stomach: a clinicopathological comparison with the other histological typesTohoku J Exp Med1998186212113010223615
   PubMed Web of Science ®Google Scholar
• MaeharaYSakaguchiYMoriguchiSSignet ring cell carcinoma of the stomachCancer1992697164516501312889
   PubMed Web of Science ®Google Scholar
• ChonHJHyungWJKimCDifferential prognostic implications of gastric signet ring cell carcinomaAnn Surg2017265594695327232252
   PubMed Web of Science ®Google Scholar
• HegerUBlankSWiechaCIs preoperative chemotherapy followed by surgery the appropriate treatment for signet ring cell containing adenocarcinomas of the esophagogastric junction and stomach?Ann Surg Oncol20142151739174824419755
   PubMed Web of Science ®Google Scholar
• MutaHNoguchiMKanaiYOchiaiANawataHHirohashiSE-cadherin gene mutations in signet ring cell carcinoma of the stomachJpn J Canc Res1996878843848
   PubMedGoogle Scholar
• WeiJXuBJinSYuLLiuBErbB pathway alterations in advanced gastric signet-ring cell carcinoma (SRCC) and the implications for targeted therapyJ Clin Oncol20173515_supple15586
   Google Scholar
• ShuYZhangWHouQPrognostic significance of frequent CLDN18-ARHGAP26/6 fusion in gastric signet-ring cell cancerNat Commun201891244729961079
   PubMedGoogle Scholar
• Cancer Genome Atlas Research NetworkComprehensive molecular characterization of gastric adenocarcinomaNature2014513751720220925079317
   PubMed Web of Science ®Google Scholar
• WongSSKimK-MTingJCGenomic landscape and genetic heterogeneity in gastric adenocarcinoma revealed by whole-genome sequencingNat Commun201451547725407104
   PubMedGoogle Scholar
• RoukosDHCurrent status and future perspectives in gastric cancer managementCancer Treat Rev200026424325510913380
   PubMed Web of Science ®Google Scholar
• ZerlinMJuliusMAKitajewskiJWnt/Frizzled signaling in angiogenesisAngiogenesis2008111636918253847
   PubMed Web of Science ®Google Scholar
• ShintoOYashiroMKawajiriHInhibitory effect of a TGFbeta receptor type-I inhibitor, Ki26894, on invasiveness of scirrhous gastric cancer cellsBr J Cancer2010102584485120145621
   PubMed Web of Science ®Google Scholar
• SantoroREttorreGMSantoroESubtotal gastrectomy for gastric cancerWorld J Gastroenterol20142038136671368025320505
   PubMed Web of Science ®Google Scholar
• MorgagniPGarceaDMarrelliDResection line involvement after gastric cancer surgery: clinical outcome in nonsurgically retreated patientsWorld J Surg200832122661266718825453
   PubMed Web of Science ®Google Scholar
• PhalanusitthephaCGrimesKLIkedaHEndoscopic features of early-stage signet-ring-cell carcinoma of the stomachWorld J Gastro-intest Endosc201577741746
   PubMedGoogle Scholar
• KimMNKimHKShimCNTumour size is related to the curability of signet ring cell early gastric cancer with endoscopic sub-mucosal dissection: a retrospective single centre studyDig Liver Dis2014461089890224973115
   PubMedGoogle Scholar
• BozzettiFMarubiniEBonfantiGMiceliRPianoCGennariLSubtotal versus total gastrectomy for gastric cancer: five-year survival rates in a multicenter randomized Italian Trial. Italian Gastrointestinal Tumor Study GroupAnn Surg1999230217017810450730
   PubMed Web of Science ®Google Scholar
• MessagerMLefevreJHPichot-DelahayeVThe impact of perioperative chemotherapy on survival in patients with gastric signet ring cell adenocarcinoma: a multicenter comparative studyAnn Surg2011254568469322005144
   PubMed Web of Science ®Google Scholar
• RobbWBMessagerMGronnierCHigh-grade toxicity to neoadjuvant treatment for upper gastrointestinal carcinomas: what is the impact on perioperative and oncologic outcomes?Ann Surg Oncol201522113632363925676845
   PubMed Web of Science ®Google Scholar
• RougierPDucreuxMMahjoubiMEfficacy of combined 5-fluorouracil and cisplatinum in advanced gastric carcinomas. A phase II trial with prognostic factor analysisEur J Cancer199430A9126312697999410
   PubMed Web of Science ®Google Scholar
• HultmanBMahtemeHSundbomMLjungmanMLarssonRNygrenPBenchmarking of gastric cancer sensitivity to anti-cancer drugs ex vivo as a basis for drug selection in systemic and intraperitoneal therapyJ Exp Clin Canc Res201433110
   PubMed Web of Science ®Google Scholar
• ChenLShiYYuanJEvaluation of docetaxel- and oxaliplatin-based adjuvant chemotherapy in postgastrectomy gastric cancer patients reveals obvious survival benefits in docetaxel-treated mixed signet ring cell carcinoma patientsMed Oncol201431915925119501
   PubMed Web of Science ®Google Scholar
• KimSFiteniFPaget-BaillySThe impact of taxane-based preoperative chemotherapy in gastroesophageal signet ring cell adeno-carcinomasJ Hematol Oncol201585225976888
   PubMed Web of Science ®Google Scholar
• PernotSMitryESamalinEBiweekly docetaxel, fluorouracil, leucovorin, oxaliplatin (TEF) as first-line treatment for advanced gastric cancer and adenocarcinoma of the gastroesophageal junction: safety and efficacy in a multicenter cohortGastric Canc2014172341347
   PubMed Web of Science ®Google Scholar
• PernotSDubreuilOTougeronDDocetaxel, 5FU, oxaliplatin (TEFOX) in 1st line treatment of signet ring cell and/or poorly differentiated gastric adenocarcinoma: a retrospective study of AGEOJ Clin Oncol201533 Suppl AbstrE15048
   Web of Science ®Google Scholar
• CunninghamSCKamangarFKimMPSurvival after gastric adenocarcinoma resection: eighteen-year experience at a single institutionJ Gastrointest Surg2005971872515862270
   PubMed Web of Science ®Google Scholar
• LuMYangZFengQThe characteristics and prognostic value of signet ring cell histology in gastric cancer: a retrospective cohort study of 2199 consecutive patientsMedicine20169527e405227399088
   PubMed Web of Science ®Google Scholar
• LemoineNAdenisABoucheOSignet ring cells and efficacy of first-line chemotherapy in advanced gastric or Oesogastric junction adenocarcinomaAnticancer Res201636105543555027798928
   PubMed Web of Science ®Google Scholar
• KönigsrainerIHorvathPStrullerFKönigsrainerABeckertSBeckertinitialSInitial clinical experience with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in signet-ring cell gastric cancer with peritoneal metastasesJ Gastric Cancer201414211712225061539
   PubMedGoogle Scholar